Prospective

(redirected from prospective trial)
Also found in: Dictionary, Thesaurus.

LAW, PROSPECTIVE. One which provides for, and regulates the future acts of men, and does not interfere in any way with what has past.

PROSPECTIVE. That which is applicable to the future; it is used in opposition to retrospective. To be just, a law ought always to be prospective. 1 Bouv. Inst. n. 116.

References in periodicals archive ?
VolitionRx's assays are also being investigated in an expanded German prospective trial in patients with the 20 most common cancer types and matched healthy individuals and those with competing conditions.
Life sciences company Allenex AB (STO:ALNX) on Monday announced that Tulane University Hospital, New Orleans, Louisiana, USA is scheduled to begin a prospective trial in kidney transplantation investigating the potential of cross match XM-ONE as part of the risk assessment of its patients in May.
CHICAGO--The first prospective trial pitting an over-the-counter product against a prescription medication gave the edge to the OTC product for the earliest treatment of migraine headache.
"We are planning a prospective trial of FDG-PET vs.
In a prospective trial of adult and adolescent patients with aHUS which was resistant to plasma therapy, eculizumab resulted in elimination of the requirement for dialysis, sustained improvement in the estimated glomerular filtration rate (eGFR), and sustained improvement in hematologic parameters that correlate with aHUS disease activity.
He based his conclusion on comparisons of virtual colonoscopy findings and optical colonoscopy results in a prospective trial of 452 asymptomatic patients who underwent both procedures on the same day.
The open-label, prospective trial is expected to include a total of 35 patients and will be conducted at Herlev Hospital, Denmark.
Of those, one was a case study, another a nonrandomized prospective trial, and the last was a prospective randomized study, the Follow Up Serial Infusions of Natrecor (FUSION I) study, sponsored by nesiritide's maker, Scios Inc., a division of Johnson & Johnson.
He reported on 25 breast cancer patients who participated in a BioLucent-sponsored prospective trial in which they underwent routine surveillance mammography with and without a MammoPad.
In their randomized prospective trial, 122 patients were assigned to receive the customary dosage of enalapril (the maximal tolerated dosage, up to 10 mg twice daily); 126 patients were assigned to receive higher dosages (the maximal tolerated dosage, up to 30 mg twice daily).
Sixty patients (mean age 65 years) who presented to a hospital outpatient clinic with chronic obstructive pulmonary disease (COPD) were randomized to either a 6-month program of intensive pulmonary rehabilitation followed by a 6-month maintenance program plus standard medical care or just medical care in a prospective trial (Chest 117[4]: 976-83, 2000).

Full browser ?